Caverject
- Product NDC
- 0009-7686
- 11-digit product format
- 000097686
- Labeler code
- 0009
- Product ID
- 0009-7686_c9c81920-1b63-4318-9cc1-38cc4d3fa601
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alprostadil
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRACAVERNOUS
- Labeler
- Pharmacia & Upjohn Company LLC
- Application
- NDA020379
- Marketing category
- NDA
- Marketing start
- 1995-07-06
- Substance
- ALPROSTADIL
- Active strength
- 41.1 ug/mL
- Pharmacologic classes
- Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Caverject
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALPROSTADIL | 41.1 ug/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F5TD010360 |
| Rxcui | 103956, 226921, 226922, 242691 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0009-7686-01 | Caverject | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | | 19 |
| 0009-7686-04 | Caverject | 6 in 1 PACKAGE | INJECTION, POWDER, LYOPHILIZED, | 6 | | 19 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ALPROSTADIL | ACTIVE INGREDIENT | F5TD010360 | CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| ALPROSTADIL | ACTIVE MOIETY | F5TD010360 | CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 6 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0009-7686 | CAVERJECT (ALPROSTADIL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PHARMACIA & UPJOHN COMPANY LLC] | 19 | Current NDC, Legacy NDC, 2 package rows | 20240517_a295fc1e-d82c-4f44-bc2d-a552bf594c98.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0009-7686-01 | 00009768601 | 1 mL in 1 VIAL, SINGLE-DOSE | 1 ml | | | | | Historical |
| 0009-7686-04 | 00009768604 | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-7686-04) / 1 mL in 1 VIAL, SINGLE-DOSE (0009-7686-01) | | 1995-07-06 | 0000-00-00 | No | No | Current |